TRAC and familial pancreatic carcinoma: Therefore, TRAC KO probably will not decrease the CAR T cell efficacy, and the studies on the lower efficacy of allogeneic CAR T cells might be incidental or dependent on the context (e.g. pancreatic cancer in Wang et al. [53]).